Estimation of Serum Lipid Profile among Patients Admitted with Myocardial Infarction in a Tertiary Level Hospital of

N A Siddique1, M S Rahman, N Islam

  • 1Dr Nure Alam Siddique, Assistant Professor, Department of Cardiology, Mymensingh Medical College (MMC), Mymensingh, Bangladesh;

Insights

Dyslipidemia is a significant risk factor in myocardial infarction (MI) patients, with high triglycerides and total cholesterol observed. Lifestyle modifications are recommended to manage dyslipidemia in individuals with ischemic heart disease.

Area of Science:

  • Cardiology
  • Clinical Biochemistry
  • Public Health

Background:

  • Dyslipidemia is a known contributor to the development of ischemic heart diseases (IHD).
  • Understanding lipid profiles in myocardial infarction (MI) patients is crucial for risk stratification and management.

Purpose of the Study:

  • To estimate the lipid profile of patients admitted to the coronary care unit (CCU) with myocardial infarction (MI).
  • To identify the prevalence of dyslipidemia and associated risk factors among MI patients.

Main Methods:

  • A cross-sectional, descriptive observational study was conducted over six months.
  • Data were collected from 343 MI patients through interviews and laboratory investigations.
  • Statistical analysis was performed using SPSS version 21.0.

Main Results:

  • The majority of MI patients were male (82.8%) with a mean age of 53.16 years.
  • Common risk factors included smoking (71.1%), hypertension (43.7%), and obesity (28.9%).
  • Dyslipidemia was present in 17.8% of patients, with elevated triglycerides (56.9%) and total cholesterol (35.3%) being most common.

Conclusions:

  • A significant proportion of MI patients exhibit dyslipidemia, underscoring its role in ischemic heart disease.
  • While lipid profiles showed no significant differences between age groups or genders, dyslipidemia requires attention.
  • Dietary and lifestyle modifications are essential for managing dyslipidemia in MI patients.

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
290
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
21
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
327
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
213
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
31